5 Results for "

KRASG12C IN-12

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "KRASG12C IN-12" in MCE Product Catalog:

Cat. No.: HY-159163
CAS No.: 2093328-45-9
Target:  

Ras

Research Areas:  

Cancer

KRASG12C IN-12 (compound-1) is a KRAS G12C inhibitor. KRASG12C IN-12 (compound-1) can form a ternary complex with intracellular CYPA and the activated KRAS G12C mutant .
loading...
    loading...
Cat. No.: HY-154313
CAS No.: 24527-27-3
Purity:  99.95%
Synonyms: Clospirazine
Target:  

Ras

Research Areas:  

Cancer

Spiclomazine (Clospirazine) is a potent mutant KRAS(G12C) inhibitor that selectively inhibits mutant KRAS-driven pancreatic cancer. Spiclomazine can eliminate KRas-GTP levels in KRAS-driven pancreatic cancer and effectively inhibit RAS-mediated signaling. Spiclomazine significantly inhibits tumor progression in mouse renal capsule xenotransplantation models .
loading...
    loading...
Cat. No.: HY-153944
Target:  

Ras

Research Areas:  

Cancer

KRAS G12C inhibitor 60 (compound 23) is a Kras-G12C inhibitor. KRAS G12C inhibitor 60 can be used for the research of lung cancer, colorectal cancer, pancreatic cancer .
loading...
    loading...
Cat. No.: HY-145022
CAS No.: 2734060-73-0
Target:  

Ras

Research Areas:  

Cancer

KRAS G12C inhibitor 25 is a KRAS G12C inhibitor. KRAS G12C inhibitor 25 inhibits SOSl-assisted GDP/GTP exchanging activity of KRAS-G12C mutant (IC50=0.48 nM). From WO2021216770A1 compound 3 .
loading...
    loading...
Cat. No.: HY-179702
KD36 is a selective KRAS-G12C inhibitor with an IC50 value of 0.92 μM. KD36 can inhibit the phosphorylation of ERK and AKT, induce the accumulation of reactive oxygen species (ROS), reduce mitochondrial membrane potential, thereby leading to apoptosis of KRAS-G12C mutant cells. KD36 can be used in the research of non-small cell lung cancer (NSCLC) .
loading...
    loading...